QUEST DIAGNOSTICS INC (DGX)
QUEST DIAGNOSTICS INC (DGX) from its SEC filings: 2025 revenue $11.0 billion (+12% vs the year before), net margin 9%, free cash flow $1.4 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Services-Medical Laboratories |
| Revenue (2025) | $11.0 billion |
| Revenue growth | +12% |
| Net income | $992.0 million |
| Net margin | 9.0% |
| Free cash flow | $1.4 billion |
| Diluted EPS | $8.75 |
| Latest quarter (Q3 2026 (calendar)) revenue vs a year earlier | +10% |
| Cash | $797.0 million |
| Long-term debt | $5.5 billion |
| Share count, 1 year | -1% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.